# Bolt Biotherapeutics (BOLT) — Analyst Forecast

BOLT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bolt/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 2 | 2 | 0 | 4 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| May 29, 2026 | Rodman & Renshaw | Initiated Coverage | Buy | $22.00 |
| May 28, 2026 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Mar 13, 2026 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Oct 20, 2025 | HC Wainwright & Co. | Initiated Coverage | Buy | $7.00 |
| Aug 15, 2025 | Lake Street | Maintained | Buy | $75.00 |
| May 20, 2025 | Lake Street | Initiated Coverage | Buy | $4.00 |
| May 13, 2025 | Stifel | Maintained | Hold | $1.00 |
| Mar 25, 2025 | Stifel | Maintained | Hold | $1.25 |
| Mar 25, 2025 | HC Wainwright & Co. | Maintained | Neutral | — |
| Nov 13, 2024 | HC Wainwright & Co. | Maintained | Neutral | — |
| Aug 15, 2024 | HC Wainwright & Co. | Maintained | Neutral | — |
| May 15, 2024 | Stifel | Downgraded | Buy → Hold | $1.50 |
| May 15, 2024 | HC Wainwright & Co. | Downgraded | Buy → Neutral | — |
| May 15, 2024 | Jones Trading | Downgraded | Buy → Hold | — |
| May 15, 2024 | Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 |
| May 15, 2024 | Guggenheim | Downgraded | Buy → Neutral | — |
| Mar 22, 2024 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Aug 8, 2023 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Aug 3, 2023 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Jun 5, 2023 | HC Wainwright & Co. | Maintained | Buy | $8.00 |

## Frequently Asked Questions

### Is BOLT a buy, sell, or hold?

Analysts covering Bolt Biotherapeutics currently average a Buy rating: 2 buy, 2 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on BOLT?

On May 29, 2026, Rodman & Renshaw initiated coverage of Bolt Biotherapeutics at Buy with a price target of $22.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).